Here are five spine and neurosurgeons making headlines.
DiscGenics principal investigator Domagoj Coric, MD, of Carolina Neurosurgery and Spine Associates in Charlotte, N.C., treated the first patient in the phase 1/phase 2 clinical trials of IDCT.
Michael Wang, MD, and his team are offering high-risk patients a new approach to spine surgery.
